The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2V617F myeloproliferative neoplasm cells
Ariel Amaru Calzada(Azienda Ospedaliero Universitaria Ospedali Riuniti), Josée Golay(Azienda Ospedaliero Universitaria Ospedali Riuniti)
Cited by 40
Related Papers
Givinostat and hydroxyurea synergize in vitro to induce apoptosis of cells from JAK2V617F myeloproliferative neoplasm patients
|Experimental Hematology|2012|33